Results 231 to 240 of about 88,563 (282)

A case of hereditary hemorrhagic telangiectasia with hypoxemia onset in the neonatal period. [PDF]

BMC Pulm Med
Zhang D, Li J, Zhou G, Yang D, Wu P, Jin Y.   +5 more
europepmc   +1 more source

A Comprehensive Analysis of the Blurring Boundary Between Cosmetic Applications and Medical Treatment

Journal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Dermatology and cosmetology have traditionally been regarded as distinct disciplines, with dermatology focused on the diagnosis and treatment of disease and cosmetology aimed at enhancing aesthetic appearance. In recent years, this distinction has become increasingly blurred due to technological advancements, expanding clinical ...
Eda Kumbasar‐Atay, Kadircan H. Keskinbora   +1 more
wiley   +1 more source

Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection? [PDF]

AIDS
Varenne F, Siegfried-Vergnon A, Lhomme S, Treiner E, Pignolet B, Joly M, Bonneville F, Gandia P, Rodriguez C, Cortese I, Martin-Blondel G, Soler V.   +11 more
europepmc   +1 more source

Oral JAK Inhibitors as a Promising Therapeutic Strategy for Refractory Rosacea: A Systematic Review and Meta‐Analysis

Journal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Rosacea is a chronic inflammatory dermatosis. While standard therapies exist, managing refractory subtypes remains a therapeutic challenge. Oral Janus kinase (JAK) inhibitors have emerged as potential alternatives, but systematic evidence is lacking. Aims To evaluate the efficacy and safety of oral JAK inhibitors for rosacea through
Yu Peng, Mingzi Sun, Jiayu Chen, Xubo Huang, Fengchuan Zhang   +4 more
wiley   +1 more source

Correction to "Hereditary hemorrhagic telangiectasia in a 68-year-old man". [PDF]

CMAJ
europepmc   +1 more source

Multiple lesion-specific somatic mutations and bi-allelic loss of ACVRL1 in a single patient with hereditary haemorrhagic telangiectasia. [PDF]

Eur J Hum Genet
Darre Haahr P, Hao Q, Brusgaard K, Larsen MJ, Lange B, Fialla AD, Kofoed MS, Kjeldsen J, Schultz NA, Kjeldsen AD, Tørring PM.   +10 more
europepmc   +1 more source

Clinical Efficacy of Tofacitinib in Treating Granulomatous Reaction After Mesotherapy: A Case Series Analysis

Journal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Mesotherapy, a widely utilized minimally invasive cosmetic procedure, carries potential risks of adverse reactions due to non‐standardized protocols and overuse. Delayed granulomatous reactions represent a chronic complication, imposing significant physical and psychological burdens on patients.
Chang Shu, Tao Zhang, Jia‐Wei Liu, Chen‐yu Zhu, Rou‐yu Fang, Qiu‐ning Sun, Nian Li, Feng Li   +7 more
wiley   +1 more source

Ataxia-Telangiectasia in Resource-Limited Settings: A Diagnostic Challenge. [PDF]

Cureus
Adeyemi E, Idowu R, Adefolaji A, Adeyemi F, Olowoyo P.   +4 more
europepmc   +1 more source

Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review

Wound Repair and Regeneration, Volume 34, Issue 2, March/April 2026.
ABSTRACT Venous leg ulcers (VLUs) are chronic wounds in the lower limbs that cause significant morbidity. The underlying biology underpinning non‐healing in VLUs is still poorly understood and differences in transcriptomic profiles may help elucidate biological pathways involved in wound chronicity.
Chien Lin Soh, Kia Hau Matthew Tan, Alun Huw Davies, Sarah Onida   +3 more
wiley   +1 more source

Nasal Septal Perforation and Hereditary Hemorrhagic Telangiectasia: Evolution in Management. [PDF]

Laryngoscope Investig Otolaryngol
Bansberg SF, House T, Lal D, Marino MJ, Taylor CM, Miglani A.   +5 more
europepmc   +1 more source